There were no statistically significant differences observed in eNOS phosphorylation (Figure 4A), a marker of endothelial dysfunction, between HCAECs treated with plasma-derived small ECVs from healthy volunteers and untreated HCAECs. Here, NOS3 is linked to endothelial dysfunction.